A Phase 1, multi-center, open-label pharmacokinetic and safety study of amifampridine in healthy subjects with impaired renal function.
Phase of Trial: Phase I
Latest Information Update: 21 Sep 2016
At a glance
- Drugs Amifampridine (Primary)
- Indications Lambert-Eaton myasthenic syndrome
- Focus Adverse reactions; Pharmacokinetics
- 21 Sep 2016 New trial record